Crowne Health Care Of Citronelle | |
19225 North 4th Street, Citronelle, Alabama 36522 | |
(251) 866-5509 | |
Name | Crowne Health Care Of Citronelle |
---|---|
Location | 19225 North 4th Street, Citronelle, Alabama |
Certified By | Medicare and Medicaid |
No. of Certified Beds | 66 |
Occupancy Rate | 96.67% |
Medicare ID (CCN) | 015121 |
Legal Business Name | Crowne Health Care Of Citronelle, Llc |
Ownership Type | For Profit - Limited Liability Company |
NPI Number | 1033379854 |
Organization Name | AL CITRONELLE LLC |
Doing Business As | CITRONELLE HEALTH AND REHABILITATION CENTER |
Address | 19225 N 4th St, Citronelle, AL 36522 |
Phone Number | 334-866-5509 |
News Archive
Omeros Corporation, a biopharmaceutical company committed to discovering, developing and commercializing products focused on inflammation and disorders of the central nervous system, today announced financial results for the three and six months ended June 30, 2010.
An individualised posturing programme after macular hole surgery can significantly reduce the duration of facedown posturing without compromising outcomes, suggests research published in Retina.
Jeremy L. Steinbacher, PhD, is among a new generation of scientists trying to improve their aim and approach to killing cancer cells. The Canisius College professor of chemistry/biochemistry is working to develop biomedical agents that more accurately target and attack tumors.
Insights into how the heart recovers after myocardial infarction (heart attack) can be obtained with a new radiotracer that targets fibroblast activity prior to it causing permanent damage.
› Verified 4 days ago
NPI Number | 1437141355 |
Organization Name | DELTA HEALTH GROUP INC |
Doing Business As | CITRONELLE CONVALESCENT CENTER |
Address | 19225 N 4th St, Citronelle, AL 36522 |
Phone Number | 251-866-5509 |
News Archive
Omeros Corporation, a biopharmaceutical company committed to discovering, developing and commercializing products focused on inflammation and disorders of the central nervous system, today announced financial results for the three and six months ended June 30, 2010.
An individualised posturing programme after macular hole surgery can significantly reduce the duration of facedown posturing without compromising outcomes, suggests research published in Retina.
Jeremy L. Steinbacher, PhD, is among a new generation of scientists trying to improve their aim and approach to killing cancer cells. The Canisius College professor of chemistry/biochemistry is working to develop biomedical agents that more accurately target and attack tumors.
Insights into how the heart recovers after myocardial infarction (heart attack) can be obtained with a new radiotracer that targets fibroblast activity prior to it causing permanent damage.
› Verified 4 days ago
NPI Number | 1730530130 |
Organization Name | CROWNE HEALTH CARE OF CITRONELLE, LLC |
Address | 19225 N 4th St, Citronelle, AL 36522 |
Phone Number | 251-866-5509 |
News Archive
Omeros Corporation, a biopharmaceutical company committed to discovering, developing and commercializing products focused on inflammation and disorders of the central nervous system, today announced financial results for the three and six months ended June 30, 2010.
An individualised posturing programme after macular hole surgery can significantly reduce the duration of facedown posturing without compromising outcomes, suggests research published in Retina.
Jeremy L. Steinbacher, PhD, is among a new generation of scientists trying to improve their aim and approach to killing cancer cells. The Canisius College professor of chemistry/biochemistry is working to develop biomedical agents that more accurately target and attack tumors.
Insights into how the heart recovers after myocardial infarction (heart attack) can be obtained with a new radiotracer that targets fibroblast activity prior to it causing permanent damage.
› Verified 4 days ago
Ratings from Surveys (Inspections): | |
Ratings from Quality Measures: | |
Ratings from Staffing Data: | |
Overall Rating: |
---|
News Archive
Omeros Corporation, a biopharmaceutical company committed to discovering, developing and commercializing products focused on inflammation and disorders of the central nervous system, today announced financial results for the three and six months ended June 30, 2010.
An individualised posturing programme after macular hole surgery can significantly reduce the duration of facedown posturing without compromising outcomes, suggests research published in Retina.
Jeremy L. Steinbacher, PhD, is among a new generation of scientists trying to improve their aim and approach to killing cancer cells. The Canisius College professor of chemistry/biochemistry is working to develop biomedical agents that more accurately target and attack tumors.
Insights into how the heart recovers after myocardial infarction (heart attack) can be obtained with a new radiotracer that targets fibroblast activity prior to it causing permanent damage.
› Verified 4 days ago
Number of Facility Reported Incidents | 0 |
Number of Substantiated Complaints | 0 |
Number of Fines | 0 |
Total Amount of Fines in Dollars | $0 |
Number of Payment Denials | 0 |
Total Number of Penalties | 0 |
Experience Measure | Provider | National Avg. |
---|---|---|
Percentage of long-stay residents whose need for help with daily activities has increased | 16.11 | 14.46 |
Percentage of long-stay residents who lose too much weight | 4.07 | 5.51 |
Percentage of low risk long-stay residents who lose control of their bowels or bladder | 50.53 | 48.41 |
Percentage of long-stay residents with a catheter inserted and left in their bladder | 1.4 | 1.79 |
Percentage of long-stay residents with a urinary tract infection | 1.3 | 2.65 |
Percentage of long-stay residents who have depressive symptoms | 0.87 | 5.05 |
Percentage of long-stay residents who were physically restrained | 0.84 | 0.23 |
Percentage of long-stay residents experiencing one or more falls with major injury | 3.78 | 3.36 |
Percentage of long-stay residents assessed and appropriately given the pneumococcal vaccine | 98.32 | 93.87 |
Percentage of long-stay residents who received an antipsychotic medication | 9.13 | 14.2 |
Percentage of short-stay residents assessed and appropriately given the pneumococcal vaccine | 98.26 | 83.88 |
Percentage of short-stay residents who newly received an antipsychotic medication | 0 | 1.79 |
Percentage of long-stay residents whose ability to move independently worsened | 16.34 | 17.09 |
Percentage of long-stay residents who received an antianxiety or hypnotic medication | 22.81 | 19.7 |
Percentage of high risk long-stay residents with pressure ulcers | 8.24 | 7.32 |
Percentage of long-stay residents assessed and appropriately given the seasonal influenza vaccine | 98.83 | 95.98 |
Percentage of short-stay residents who made improvements in function | 78.8 | 67.99 |
Percentage of short-stay residents who were assessed and appropriately given the seasonal influenza vaccine | 90.73 | 82.93 |
News Archive
Omeros Corporation, a biopharmaceutical company committed to discovering, developing and commercializing products focused on inflammation and disorders of the central nervous system, today announced financial results for the three and six months ended June 30, 2010.
An individualised posturing programme after macular hole surgery can significantly reduce the duration of facedown posturing without compromising outcomes, suggests research published in Retina.
Jeremy L. Steinbacher, PhD, is among a new generation of scientists trying to improve their aim and approach to killing cancer cells. The Canisius College professor of chemistry/biochemistry is working to develop biomedical agents that more accurately target and attack tumors.
Insights into how the heart recovers after myocardial infarction (heart attack) can be obtained with a new radiotracer that targets fibroblast activity prior to it causing permanent damage.
› Verified 4 days ago
Crowne Health Care Of Citronelle Location: 19225 North 4th Street, Citronelle, Alabama 36522 Phone: (251) 866-5509 |